does blue cross cover glp-1 Blue Shield of Mass. sees gains after years of GLP-1-related losses Alberta Blue Cross 2026 Pipeline:

Novo Nordisk has a GLP-1 pill for diabetes, Rybelsus, but its not as effective for weight loss as injectable versions and was never approved for weight management

Cold medication stings more during injection

In contrast, in a metanalysis of 12 randomized, double-blind, placebo-controlled trials comprising 3065 of 73 238 participants (4.2%) with diabetes who were using GLP-1 RAs at baseline, SGLT2i reduced the risk of CKD progression in participants both receiving and not receiving GLP-1 RAs [HR 0.65 (95% CI 0.460.94) versus HR 0.67 (95% CI 0.620.72)

obesity GLP-1 market size is calculated at USD 3.69 billion in 2025 and is expected to reach nearly USD 30.41 billion in 2035, accelerating at a strong CAGR of 23.48% between 2026 and 2035

Because the pill mimics natural hormone functions, it travels to the brain to target the reward centers that drive overeating, says Sara Velayati, MD, an obesity medicine specialist at the Fleischer Institute Medical Weight Center at Montefiore Einstein in New York